Internal Medicine, Hematology & Oncology · Spokane, WA
NPI
1952445223
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
601 S Sherman St
Spokane, WA, 99202
Phone (509) 228-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.4M
233,711 services
Medicare patients, 2024
714
Average age 75
Drug cost, 2024
$1.2M
2,702 prescriptions
Company payments, 2025
$3,439
From 34 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Saritha C Thumma was code Q5125 (injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram), 47,640 times for 25 patients. In total Saritha C Thumma billed 233,711 services in 155 codes, and Medicare paid $3.4M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-08.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q5125 Injection, filgrastim-ayow, biosimilar, (releuko), 1 microgram | Office | 47,640 | 25 | $0.38 | $18K |
| J0897 Injection, denosumab, 1 mg | Office | 10,440 | 72 | $20.22 | $211K |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 9,935 | 63 | $0.11 | $1,059 |
| J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj | Office | 9,720 | 20 | $39.14 | $380K |
| J9267 Injection, paclitaxel, 1 mg | Office | 9,423 | 12 | $0.08 | $754 |
| J0185 Injection, aprepitant, 1 mg | Office | 7,930 | 24 | $1.32 | $10K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 5,200 | 17 | $44.33 | $231K |
| J1930 Injection, lanreotide, 1 mg | Office | 3,960 | 12 | $38.30 | $152K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,232 | 91 | $0.09 | $284 |
| Q5114 Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg | Office | 2,807 | 11 | $41.90 | $118K |
| J1323 Injection, elranatamab-bcmm, 1 mg | Office | 2,056 | 15 | $141.18 | $290K |
| J9395 Injection, fulvestrant, 25 mg | Office | 1,960 | 20 | $6.32 | $12K |
| J0461 Injection, atropine sulfate, 0.01 mg | Office | 1,840 | 12 | $0.06 | $119 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 1,710 | 22 | $37.22 | $64K |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 1,480 | 40 | $0.24 | $358 |
By year: 2022 $6.0M for 403,867 services; 2023 $3.8M for 249,911 services; 2024 $3.4M for 233,711 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,001 | 364 | $8.57 | $8,576 |
| 85025 Blood Count | 535 | 134 | $7.56 | $4,046 |
| 85027 Blood Count | 463 | 280 | $6.32 | $2,925 |
| 81002 Clinical Chemistry | 31 | 17 | $3.41 | $106 |
Medicare prescription drug claims, 2024
In 2024, the drug Saritha C Thumma prescribed most often to Medicare patients was Letrozole, with 892 prescriptions and refills. In total Saritha C Thumma wrote 2,702 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 892 | 2,231 | 233 | $22K |
| Anastrozole Generic | 499 | 1,284 | 135 | $8,734 |
| Alendronate Sodium Generic | 215 | 535 | 69 | $1,945 |
| Exemestane Generic | 131 | 284 | 37 | $11K |
| Gabapentin Generic | 90 | 203 | 26 | $1,993 |
| Potassium Chloride Generic | 69 | 145 | 21 | $1,192 |
| Omeprazole Generic | 57 | 106 | 18 | $886 |
| Tamoxifen Citrate Generic | 51 | 119 | 14 | $1,376 |
| Venlafaxine Hcl Er Venlafaxine Hcl | 49 | 122 | 14 | $955 |
| Ibrance Palbociclib | 38 | 38 | Under 11 | $596K |
| Azithromycin Generic | 34 | 34 | 28 | $126 |
| Levothyroxine Sodium Generic | 33 | 99 | Under 11 | $439 |
| Prochlorperazine Maleate Generic | 31 | 31 | 17 | $725 |
| Ondansetron Odt Ondansetron | 26 | 26 | 12 | $403 |
| Methylprednisolone Generic | 26 | 26 | 18 | $213 |
Brand drugs: 174 claims; generic drugs: 2,528 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Saritha C Thumma $3,439 ($3,439 in general payments such as food, travel and fees) from 34 companies. The largest payer was Novartis Pharmaceuticals Corporation with $1,431.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 32 | $1,431 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $216 |
| Pfizer Inc. PFE | 10 | $192 |
| Merck Sharp & Dohme LLC MRK | 6 | $143 |
| Abbvie Inc. ABBV | 5 | $137 |
| GlaxoSmithKline, LLC. GSK | 5 | $114 |
| Celgene Corporation BMY | 3 | $75.52 |
| Array Biopharma Inc PFE | 3 | $67.81 |
| Dendreon Pharmaceuticals LLC | 2 | $64.22 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $64.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.